Customer Support: +919024236503

Need Help?

  • Share via whatsapp

Imatinib IP (400mg) IMATIFLOW 400: Detailed Overview of Uses, Dosage, and Potential Side Effects

Jul 18, 2024

IMATIFLOW 400

Imatinib IP (400mg)

Introduction

IMATIFLOW 400, containing Imatinib IP (400mg), is a groundbreaking medication widely used in oncology. It plays a critical role in managing chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). This medication functions as a tyrosine kinase inhibitor, targeting specific proteins responsible for cancer cell growth. This detailed overview covers the uses, dosage, side effects, price, and additional information about Imatinib IP (400mg).

Uses

Imatinib IP (400mg) is predominantly used to treat chronic myeloid leukemia (CML), where it significantly improves patient outcomes by inhibiting the BCR-ABL tyrosine kinase enzyme. This enzyme is produced by the Philadelphia chromosome abnormality, which drives the uncontrolled proliferation of white blood cells. Imatinib is also effective in treating Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), a fast-growing form of leukemia. Another critical application of this drug is in the treatment of gastrointestinal stromal tumors (GISTs), a type of tumor found in the digestive tract. Additionally, Imatinib is used for treating myelodysplastic/myeloproliferative diseases (MDS/MPD) and dermatofibrosarcoma protuberans (DFSP), a rare skin cancer. By blocking the action of the tyrosine kinase enzyme, Imatinib helps to control the growth and spread of cancer cells.

Dosage

The appropriate dosage of IMATIFLOW 400 depends on the specific cancer type and the patient's response to treatment. For chronic myeloid leukemia (CML), the standard dose is 400mg taken once daily, which can be increased to 600mg or 800mg if necessary. Patients with gastrointestinal stromal tumors (GISTs) typically start with a dose of 400mg daily, which may be adjusted based on their response to the therapy. For Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), the dose is generally 600mg daily. It is important to take IMATIFLOW 400 with food and a full glass of water to reduce the risk of gastrointestinal side effects. Patients should strictly follow their healthcare provider's dosing instructions and not make any changes without consultation.

Side Effects

Imatinib IP (400mg) can cause a range of side effects, varying in severity from mild to serious. Common side effects include nausea, vomiting, diarrhea, and muscle cramps. Patients might also experience rashes, fatigue, and headaches. Some individuals may develop fluid retention, leading to swelling, particularly in the lower extremities or around the eyes. More severe side effects can include liver function abnormalities, low blood cell counts, which increase the risk of infection and bleeding, and gastrointestinal bleeding. Patients should promptly report any severe or unusual symptoms to their healthcare provider. Regular monitoring through blood tests and check-ups is crucial to manage these side effects effectively.

Price

The cost of IMATIFLOW 400 varies across different pharmacies and regions. Typically, the price for a one-month supply of Imatinib IP (400mg) in India ranges between ₹25,000 and ₹35,000. Patients should consult with their healthcare provider or pharmacist for the most accurate and current pricing information and to explore potential insurance coverage or assistance programs.

More Information

Patients on IMATIFLOW 400 should maintain regular appointments with their healthcare provider to monitor the effectiveness of the treatment and make necessary dosage adjustments. It is essential to adhere to the prescribed regimen and report any side effects or concerns to the medical team promptly. Patients should inform their healthcare provider of all other medications they are taking to prevent potential drug interactions. Leading a healthy lifestyle, including a balanced diet and regular physical activity, can enhance overall well-being and support the treatment's efficacy. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company's mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it's advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma  Order Now Sterispharma's extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information:

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488

Buy Now:

SHARE WITH

  • Share via whatsapp